You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR TIVDAK


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TIVDAK

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03245736 ↗ Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. Completed Genmab Phase 2 2017-08-23 The purpose of the trial is to evaluate efficacy and safety of continued treatment with tisotumab vedotin.
NCT03245736 ↗ Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. Completed Seagen Inc. Phase 2 2017-08-23 The purpose of the trial is to evaluate efficacy and safety of continued treatment with tisotumab vedotin.
NCT03438396 ↗ A Trial of Tisotumab Vedotin in Cervical Cancer Active, not recruiting Belgian Gynaecological Oncology Group Phase 2 2018-06-12 A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
NCT03438396 ↗ A Trial of Tisotumab Vedotin in Cervical Cancer Active, not recruiting European Network of Gynaecological Oncological Trial Groups (ENGOT) Phase 2 2018-06-12 A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
NCT03438396 ↗ A Trial of Tisotumab Vedotin in Cervical Cancer Active, not recruiting Genmab Phase 2 2018-06-12 A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
NCT03438396 ↗ A Trial of Tisotumab Vedotin in Cervical Cancer Active, not recruiting Gynecologic Oncology Group Phase 2 2018-06-12 A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
NCT03438396 ↗ A Trial of Tisotumab Vedotin in Cervical Cancer Active, not recruiting Seattle Genetics, Inc. Phase 2 2018-06-12 A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TIVDAK

Condition Name

Condition Name for TIVDAK
Intervention Trials
Bladder Cancer 1
Cervical Cancer 1
Cervix Cancer 1
Endometrium Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TIVDAK
Intervention Trials
Uterine Cervical Neoplasms 2
Carcinoma, Squamous Cell 1
Urinary Bladder Neoplasms 1
Carcinoma, Non-Small-Cell Lung 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TIVDAK

Trials by Country

Trials by Country for TIVDAK
Location Trials
United States 19
Spain 1
United Kingdom 1
Czechia 1
Italy 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TIVDAK
Location Trials
Florida 2
South Carolina 1
New Jersey 1
New Mexico 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TIVDAK

Clinical Trial Phase

Clinical Trial Phase for TIVDAK
Clinical Trial Phase Trials
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TIVDAK
Clinical Trial Phase Trials
Active, not recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TIVDAK

Sponsor Name

Sponsor Name for TIVDAK
Sponsor Trials
Genmab 4
Seagen Inc. 2
Belgian Gynaecological Oncology Group 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TIVDAK
Sponsor Trials
Industry 7
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.